<DOC>
	<DOCNO>NCT01123538</DOCNO>
	<brief_summary>The purpose study compare combine postmenopausal hormone therapy natural progesterone one containing synthetic progestagen ( i.e . chlormadinone acetate ) blood transcriptome level .</brief_summary>
	<brief_title>Progestagen Type Postmenopausal Hormone Therapy Blood Gene Expression Profile</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Progestins</mesh_term>
	<mesh_term>Chlormadinone Acetate</mesh_term>
	<criteria>Postmenopausal woman define : 45 year &lt; age &lt; 65 year Amenorrhoeic ≥ 1 year Amenorrhoeic &lt; 1 year either without withdrawal vaginal bleeding 3 consecutive month spite cyclic progestagen treatment and/or blood estradiol level ≤ 20 pg/mL blood FSH level ≥ 40 UI/mL Women bilateral ovariectomy Women suffer least 1 postmenopausal symptom list : Hot flash , Memory Concentration Problems , Mood Swings , Insomnia , Urinary Incontinence , Night sweating , Join pain , Asthenia . No use hormone therapy ( HT ) Previous HT user : HT use &lt; 3 month stop 6 month HT use &lt; = 1 year stop &gt; 12 month If previous use soya derivative dietary supplement : washout period = 3 month Signed informed consent , receive oral write information regard study goal , risk benefit constraint , include 12 month followup . A delay respect information signature write consent . Past HT user use treatment 1 year Hysterectomized woman Women without health insurance ( French centre ) History cardiovascular accident either arterial venous Untreated high blood pressure Liver disease Diabetes History cancer except basalcell skin cancer colon cancer Severe history familial breast cancer define least 2 woman first degree relative breast cancer diagnosis 50 year History severe mastalgia History breast biopsy show hyperplasia ( without atypia ) Undiagnosed vaginal bleeding Diagnosed endometrial hyperplasia Autoimmune disease ( e.g . lupus ) Women kidney transplant</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>